−0.1954 SEK
−12.13 M SEK
16.41 M SEK
About LIPIGON PHARMACEUTICALS AB
Sector
CEO
Johan Liwing
Headquarters
Umeå
Website
Founded
2010
ISIN
SE0015382072
FIGI
BBG00Z6DTDL4
Lipigon Pharmaceuticals AB engages in the development of drugs for diseases caused by disruptions in the body's handling of lipids. It focuses on small molecules, gene therapy, and antisense for patients with lipid disorders and other cardiometabolic risk factors. Lipigon products include P1 lipisense, P3 dyslipidemia and P4 CAP. The company was founded by Stefan Kristoffer Nilsson on April 6, 2010 and is headquartered in Umeå, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LPGO is 0.1154 SEK — it has decreased by −17.33% in the past 24 hours. Watch LIPIGON PHARMACEUTICALS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange LIPIGON PHARMACEUTICALS AB stocks are traded under the ticker LPGO.
LPGO stock has fallen by −29.45% compared to the previous week, the month change is a −35.36% fall, over the last year LIPIGON PHARMACEUTICALS AB has showed a −76.69% decrease.
We've gathered analysts' opinions on LIPIGON PHARMACEUTICALS AB future price: according to them, LPGO price has a max estimate of 0.90 SEK and a min estimate of 0.90 SEK. Watch LPGO chart and read a more detailed LIPIGON PHARMACEUTICALS AB stock forecast: see what analysts think of LIPIGON PHARMACEUTICALS AB and suggest that you do with its stocks.
LPGO reached its all-time high on Mar 1, 2021 with the price of 10.6666 SEK, and its all-time low was 0.0940 SEK and was reached on Dec 27, 2024. View more price dynamics on LPGO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LPGO stock is 21.73% volatile and has beta coefficient of 1.40. Track LIPIGON PHARMACEUTICALS AB stock price on the chart and check out the list of the most volatile stocks — is LIPIGON PHARMACEUTICALS AB there?
Today LIPIGON PHARMACEUTICALS AB has the market capitalization of 14.24 M, it has decreased by −23.91% over the last week.
Yes, you can track LIPIGON PHARMACEUTICALS AB financials in yearly and quarterly reports right on TradingView.
LPGO net income for the last quarter is −6.72 M SEK, while the quarter before that showed −415.00 K SEK of net income which accounts for −1.52 K% change. Track more LIPIGON PHARMACEUTICALS AB financial stats to get the full picture.
No, LPGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LIPIGON PHARMACEUTICALS AB EBITDA is −21.80 M SEK, and current EBITDA margin is −76.51%. See more stats in LIPIGON PHARMACEUTICALS AB financial statements.
Like other stocks, LPGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIPIGON PHARMACEUTICALS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LIPIGON PHARMACEUTICALS AB technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LIPIGON PHARMACEUTICALS AB stock shows the sell signal. See more of LIPIGON PHARMACEUTICALS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.